Akihiro Yoshitake

Saitama Medical University
Country flagJapan

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (21)

Background In some patients, transcatheter aortic valve implantation (TAVI) is associated with conduction disturbances, necessitating permanent pacemaker implantation (PMI). The clinical course of conduction disturbances after PMI, based on the type of TAVI valve, remains unclear. Therefore, the present study aimed to evaluate the effects of different types of TAVI valves on the clinical course of conduction disturbances. Methods In total, 480 patients, including 230 with self‐expandable (SE) valves and 250 with balloon‐expandable (BE) valves, who underwent TAVI between January 2016 and December 2024, were enrolled in this study. The characteristics of patients who required PMI and the changes in the ventricular pacing ratio were compared. Results There was no significant difference in PMI factors depending on the type of valve. Computed tomography (CT) images showed that the length of the membranous septum (MS) in the PMI group did not differ from the length of the MS in the non‐PMI group. There was a significant difference in improvement in autologous AV conduction between the SE and BE groups at PMI time (SE group vs. BE group; 11/15 [66.7%] vs. 3/11 [27.3%], p = 0.047). At 1 month follow‐up, the SE group improved significantly compared to the BE group (SE vs. BE; 14/15 [93.3%] vs. 4/11 [33.3%], p = 0.002). Conclusion Restoration of autologous AV conduction and subsequent decrease in ventricular pacing ratio were more likely in the SE group and less variable in the BE group. This result indicates that PM dependency can be reduced by using an extended AVD setting or AVH.

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Objective This study aimed to report “real-world” mid-term clinical experiences and outcomes after surgical mitral valve replacement with the Epic bioprosthesis in a high-volume Japanese heart center. Methods Patients undergoing surgical mitral valve replacement with the Epic bioprosthesis from 2012 to 2023 were enrolled. Postoperative outcomes, survival, and hemodynamic performance were analyzed. The study endpoints were all-cause mortality, freedom from mitral valve reintervention, and major adverse cardiac events. Results A total of 122 patients (mean age: 73 ± 8 years, 73 males) successfully underwent surgical mitral valve replacement with the Epic bioprosthesis (25 mm, n = 22; 27 mm, n = 37; 29 mm, n = 26; and 31 mm, n = 37). The primary valve etiologies were infective endocarditis ( n = 17), stenosis ( n = 18), stenosis and regurgitation ( n = 13), regurgitation ( n = 73), and thrombosis ( n = 1). The median follow-up period was 33 (interquartile range: 20–48) months. Overall survival rates at 1, 3, and 5 years after mitral valve replacement were 86.8%, 82.0%, and 76.9%. The rates of freedom from rehospitalization for heart failure were 96.7% at 1 year, 95.5% at 3 years, and 91.2% at 5 years. The mean pressure gradient was 5 (interquartile range: 4–6.4) mmHg at discharge, 5.4 (interquartile range: 4.3–6.9) mmHg at 1 year, and 5.4 (interquartile range: 4–7.5) mmHg at late follow-up (Friedman test, p = 0.46). During the study period, only one patient required reintervention because of valve deterioration at 31 postoperative months. Conclusion The clinical outcomes of mitral valve replacement with the Epic bioprosthesis are satisfactory, with stable hemodynamics and extremely low incidence of structural valve deterioration and reintervention over 5 years.

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2020

Collaborators (4)

Ritsushi Kato

-

JAPAN
View details

Mieko Tokano

Saitama Medical University

JAPAN
View details

Hiroaki Aizawa

National Cerebral and Cardiovascular Center

JAPAN
View details

Yuuki Bamba

Assistant Professor

Niigata University Medical and Dental Hospital

JAPAN
View details